What is Wolfe Research's price target for MATX?

Wolfe Research's latest stated price target for Matson Inc. (MATX) is $142, from its action on Nov 7, 2025.

What is Wolfe Research's rating on MATX?

Wolfe Research rates MATX Outperform, a bullish rating, as of Nov 7, 2025.

When did Wolfe Research last change its view on MATX?

On Nov 7, 2025, Wolfe Research upgrades to Outperform from Peer Perform, price target $142.

Wolfe Research MATX price target and rating history

Matson Inc. (MATX) · Consumer Discretionary

Wolfe Research rates Matson Inc. (MATX) Outperform with a $142 price target, as of its latest action on Nov 7, 2025. It has published 5 rating actions on MATX since August 2022, including 3 upgrades and 1 downgrade.

Current rating: Outperform
Price target: $142
Median target, all firms: Too few
Actions on MATX: 5

Wolfe Research price target on MATX

Wolfe Research price target on MATX, each point a stated target, August 2022 to November 2025.

Every Wolfe Research rating on MATX

Nov 7, 2025
UpgradeWolfe Research upgrades to Outperform from Peer Perform, price target $142
Nov 18, 2024
DowngradeWolfe Research downgrades to Peer Perform from Outperform
Oct 4, 2023
UpgradeWolfe Research upgrades to Outperform from Peer Perform, price target $113
Nov 17, 2022
UpgradeWolfe Research upgrades to Peer Perform from Underperform
Aug 16, 2022
InitiateWolfe Research starts coverage at Underperform, price target $80

Questions about Wolfe Research and MATX

What is Wolfe Research's price target for MATX?: Wolfe Research's latest stated price target for Matson Inc. (MATX) is $142, from its action on Nov 7, 2025.
What is Wolfe Research's rating on MATX?: Wolfe Research rates MATX Outperform, a bullish rating, as of Nov 7, 2025.
When did Wolfe Research last change its view on MATX?: On Nov 7, 2025, Wolfe Research upgrades to Outperform from Peer Perform, price target $142.

All Wolfe Research ratings MATX news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.